Matches in Wikidata for { <http://www.wikidata.org/entity/Q90787839> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q90787839 description "article scientifique publié en 2020" @default.
- Q90787839 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q90787839 description "im April 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q90787839 description "scientific article published on 01 April 2020" @default.
- Q90787839 description "wetenschappelijk artikel" @default.
- Q90787839 description "наукова стаття, опублікована 1 квітня 2020" @default.
- Q90787839 name "Effect of the patient information brochure in communicating the risks associated with crizotinib treatment to patients with non-small cell lung cancer (NSCLC) in Europe" @default.
- Q90787839 name "Effect of the patient information brochure in communicating the risks associated with crizotinib treatment to patients with non-small cell lung cancer (NSCLC) in Europe" @default.
- Q90787839 type Item @default.
- Q90787839 label "Effect of the patient information brochure in communicating the risks associated with crizotinib treatment to patients with non-small cell lung cancer (NSCLC) in Europe" @default.
- Q90787839 label "Effect of the patient information brochure in communicating the risks associated with crizotinib treatment to patients with non-small cell lung cancer (NSCLC) in Europe" @default.
- Q90787839 prefLabel "Effect of the patient information brochure in communicating the risks associated with crizotinib treatment to patients with non-small cell lung cancer (NSCLC) in Europe" @default.
- Q90787839 prefLabel "Effect of the patient information brochure in communicating the risks associated with crizotinib treatment to patients with non-small cell lung cancer (NSCLC) in Europe" @default.
- Q90787839 P1433 Q90787839-46092E64-D66A-405D-8741-FA7122583C74 @default.
- Q90787839 P1476 Q90787839-0D42D866-39FB-4F19-9749-83D00E3F584F @default.
- Q90787839 P2093 Q90787839-60C8A148-9FEF-4C10-9665-09A3150F49C8 @default.
- Q90787839 P2093 Q90787839-627BF332-9942-49ED-890C-7C675A403BD7 @default.
- Q90787839 P2093 Q90787839-62D1B8C0-FAEE-49F1-BF1A-1C85A18886DA @default.
- Q90787839 P2093 Q90787839-9FFC5C62-1403-4A6A-AC7B-DF165CD3AAC9 @default.
- Q90787839 P2093 Q90787839-D0E5631F-777E-4FB7-810A-00668E32B2D6 @default.
- Q90787839 P304 Q90787839-B8F66C1D-2A0A-4B0A-B771-00C341DE3314 @default.
- Q90787839 P31 Q90787839-C3D2D7AC-C3E8-43C6-9BE6-95F0D54F3C50 @default.
- Q90787839 P356 Q90787839-6E9A4CC4-ACE5-4991-B73F-4220A168B62B @default.
- Q90787839 P433 Q90787839-8EE16D4C-CF27-4C25-973A-1E66FC8F1D8A @default.
- Q90787839 P478 Q90787839-44B2572A-B2F6-4B79-92A2-2B8F0A18EDE0 @default.
- Q90787839 P50 Q90787839-46892DA2-4BED-4BE8-A762-7DF8140286DF @default.
- Q90787839 P577 Q90787839-2E193A28-2573-4353-9617-C0760F56D272 @default.
- Q90787839 P698 Q90787839-32DE36FD-ED1C-410B-9C84-DCB4FDECF7BF @default.
- Q90787839 P921 Q90787839-B8A13FF4-E604-4FDD-910C-5FA2C3416329 @default.
- Q90787839 P932 Q90787839-9F003E53-CF71-4269-8FE1-801B2B29851F @default.
- Q90787839 P356 PRP2.570 @default.
- Q90787839 P698 32232958 @default.
- Q90787839 P1433 Q27725410 @default.
- Q90787839 P1476 "Effect of the patient information brochure in communicating the risks associated with crizotinib treatment to patients with non-small cell lung cancer (NSCLC) in Europe" @default.
- Q90787839 P2093 "Beatrice Wehler" @default.
- Q90787839 P2093 "Jingping Mo" @default.
- Q90787839 P2093 "Keith D Wilner" @default.
- Q90787839 P2093 "Marcello Tiseo" @default.
- Q90787839 P2093 "Terri Madison" @default.
- Q90787839 P304 "e00570" @default.
- Q90787839 P31 Q13442814 @default.
- Q90787839 P356 "10.1002/PRP2.570" @default.
- Q90787839 P433 "2" @default.
- Q90787839 P478 "8" @default.
- Q90787839 P50 Q90787834 @default.
- Q90787839 P577 "2020-04-01T00:00:00Z" @default.
- Q90787839 P698 "32232958" @default.
- Q90787839 P921 Q3658562 @default.
- Q90787839 P932 "7105834" @default.